• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干细胞衍生的外泌体 microRNAs 作为多发性硬化症治疗的新的潜在方法。

Stem Cell-Derived Exosomal MicroRNAs as Novel Potential Approach for Multiple Sclerosis Treatment.

机构信息

Department of Anatomy, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Department of Biochemistry, Saveh University of Medical Sciences, Saveh, Iran.

出版信息

Cell Mol Neurobiol. 2024 May 7;44(1):44. doi: 10.1007/s10571-024-01478-1.

DOI:10.1007/s10571-024-01478-1
PMID:38713302
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11076329/
Abstract

Multiple Sclerosis (MS) is an autoimmune disease of the central nervous system (CNS) characterized by inflammation and demyelination of CNS neurons. Up to now, there are many therapeutic strategies for MS but they are only being able to reduce progression of diseases and have not got any effect on repair and remyelination. Stem cell therapy is an appropriate method for regeneration but has limitations and problems. So recently, researches were used of exosomes that facilitate intercellular communication and transfer cell-to-cell biological information. MicroRNAs (miRNAs) are a class of short non-coding RNAs that we can used to their dysregulation in order to diseases diagnosis. The miRNAs of microvesicles obtained stem cells may change the fate of transplanted cells based on received signals of injured regions. The miRNAs existing in MSCs may be displayed the cell type and their biological activities. Current studies show also that the miRNAs create communication between stem cells and tissue-injured cells. In the present review, firstly we discuss the role of miRNAs dysregulation in MS patients and miRNAs expression by stem cells. Finally, in this study was confirmed the relationship of microRNAs involved in MS and miRNAs expressed by stem cells and interaction between them in order to find appropriate treatment methods in future for limit to disability progression.

摘要

多发性硬化症(MS)是一种中枢神经系统(CNS)自身免疫性疾病,其特征是 CNS 神经元的炎症和脱髓鞘。到目前为止,MS 有许多治疗策略,但它们只能减缓疾病的进展,对修复和髓鞘再生没有任何影响。干细胞疗法是一种促进再生的合适方法,但有局限性和问题。因此,最近的研究使用了外泌体,外泌体可以促进细胞间的通讯并传递细胞间的生物信息。微小 RNA(miRNA)是一类短的非编码 RNA,我们可以利用它们的失调来诊断疾病。从干细胞获得的微泡中的 miRNAs 可能会根据受损区域接收到的信号改变移植细胞的命运。存在于 MSC 中的 miRNAs 可能会显示细胞类型及其生物学活性。目前的研究还表明,miRNAs 可在干细胞与组织损伤细胞之间建立通讯。在本综述中,我们首先讨论了 miRNA 失调在 MS 患者中的作用以及干细胞中的 miRNA 表达。最后,本研究证实了参与 MS 的 microRNAs 与干细胞表达的 microRNAs 之间的关系及其相互作用,以便为今后找到限制残疾进展的适当治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaca/11407200/95091536c359/10571_2024_1478_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaca/11407200/09ba0afa216d/10571_2024_1478_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaca/11407200/a419f82d5a25/10571_2024_1478_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaca/11407200/95091536c359/10571_2024_1478_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaca/11407200/09ba0afa216d/10571_2024_1478_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaca/11407200/a419f82d5a25/10571_2024_1478_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaca/11407200/95091536c359/10571_2024_1478_Fig3_HTML.jpg

相似文献

1
Stem Cell-Derived Exosomal MicroRNAs as Novel Potential Approach for Multiple Sclerosis Treatment.干细胞衍生的外泌体 microRNAs 作为多发性硬化症治疗的新的潜在方法。
Cell Mol Neurobiol. 2024 May 7;44(1):44. doi: 10.1007/s10571-024-01478-1.
2
The Role of MicroRNAs in Repair Processes in Multiple Sclerosis.微小 RNA 在多发性硬化症修复过程中的作用。
Cells. 2020 Jul 16;9(7):1711. doi: 10.3390/cells9071711.
3
Exosome Content-Mediated Signaling Pathways in Multiple Sclerosis.外泌体内容介导的多发性硬化症信号通路。
Mol Neurobiol. 2024 Aug;61(8):5404-5417. doi: 10.1007/s12035-023-03862-2. Epub 2024 Jan 8.
4
Exosomal miR-23a-3p derived from human umbilical cord mesenchymal stem cells promotes remyelination in central nervous system demyelinating diseases by targeting Tbr1/Wnt pathway.源自人脐带间充质干细胞的外泌体miR-23a-3p通过靶向Tbr1/Wnt途径促进中枢神经系统脱髓鞘疾病中的髓鞘再生。
J Biol Chem. 2024 Jan;300(1):105487. doi: 10.1016/j.jbc.2023.105487. Epub 2023 Nov 22.
5
The Therapeutic Potential of Exosomes from Mesenchymal Stem Cells in Multiple Sclerosis.间充质干细胞外泌体在多发性硬化症中的治疗潜力。
Int J Mol Sci. 2024 Sep 24;25(19):10292. doi: 10.3390/ijms251910292.
6
Exosomal Non-coding RNA Derived from Mesenchymal Stem Cells (MSCs) in Autoimmune Diseases Progression and Therapy; an Updated Review.外泌体非编码 RNA 源自间充质干细胞 (MSCs) 在自身免疫性疾病进展和治疗中的作用:最新综述。
Cell Biochem Biophys. 2024 Dec;82(4):3091-3108. doi: 10.1007/s12013-024-01432-4. Epub 2024 Sep 3.
7
Mesenchymal stem cells and their derived exosomes in multiple sclerosis disease: from paper to practice.间充质干细胞及其衍生的外泌体在多发性硬化症中的作用:从理论到实践。
Mol Cell Biochem. 2024 Jul;479(7):1643-1671. doi: 10.1007/s11010-024-05051-8. Epub 2024 Jul 8.
8
Bone marrow mesenchymal stem cells to ameliorate experimental autoimmune encephalomyelitis via modifying expression patterns of miRNAs.骨髓间充质干细胞通过改变微小RNA的表达模式改善实验性自身免疫性脑脊髓炎
Mol Biol Rep. 2023 Dec;50(12):9971-9984. doi: 10.1007/s11033-023-08843-1. Epub 2023 Oct 28.
9
Applications of Exosomal miRNAs from Mesenchymal Stem Cells as Skin Boosters.间充质干细胞来源的外泌体微小RNA作为皮肤增强剂的应用
Biomolecules. 2024 Apr 9;14(4):459. doi: 10.3390/biom14040459.
10
Modified Exosomes: a Good Transporter for miRNAs within Stem Cells to Treat Ischemic Heart Disease.改性外泌体:干细胞内 miRNA 的良好载体,可用于治疗缺血性心脏病。
J Cardiovasc Transl Res. 2022 Jun;15(3):514-523. doi: 10.1007/s12265-022-10216-1. Epub 2022 Feb 28.

引用本文的文献

1
MiR-124 and MiR-155 as Therapeutic Targets in Microglia-Mediated Inflammation in Multiple Sclerosis.微小RNA-124和微小RNA-155作为多发性硬化症中小胶质细胞介导炎症的治疗靶点
Cell Mol Neurobiol. 2025 Jul 7;45(1):63. doi: 10.1007/s10571-025-01578-6.
2
Stem Cell Therapy for Diseases of Livestock Animals: An In-Depth Review.家畜疾病的干细胞疗法:深入综述
Vet Sci. 2025 Jan 17;12(1):67. doi: 10.3390/vetsci12010067.

本文引用的文献

1
The Role of Microglial Depletion Approaches in Pathological Condition of CNS.小胶质细胞耗竭方法在中枢神经系统病理状况中的作用
Cell Mol Neurobiol. 2023 Aug;43(6):2459-2471. doi: 10.1007/s10571-023-01326-8. Epub 2023 Feb 4.
2
MicroRNAs expression in peripheral blood mononuclear cells of patients with multiple sclerosis propose.提出了多发性硬化症患者外周血单个核细胞中的微小RNA表达情况。 (原句语法有误,正确表达或许是“MicroRNAs expression in peripheral blood mononuclear cells of patients with multiple sclerosis is proposed.” )
Mol Biol Rep. 2023 Jan;50(1):167-172. doi: 10.1007/s11033-022-07905-0. Epub 2022 Nov 1.
3
Stem cell-derived and circulating exosomal microRNAs as new potential tools for diabetic nephropathy management.
干细胞衍生和循环的外泌体 microRNAs 作为糖尿病肾病管理的新潜在工具。
Stem Cell Res Ther. 2022 Jan 24;13(1):25. doi: 10.1186/s13287-021-02696-w.
4
miR-124: A Promising Therapeutic Target for Central Nervous System Injuries and Diseases.miR-124:中枢神经系统损伤和疾病的有前途的治疗靶点。
Cell Mol Neurobiol. 2022 Oct;42(7):2031-2053. doi: 10.1007/s10571-021-01091-6. Epub 2021 Apr 22.
5
Mesenchymal Stem Cell-Derived Exosomes Carry MicroRNA-125a to Protect Against Diabetic Nephropathy by Targeting Histone Deacetylase 1 and Downregulating Endothelin-1.间充质干细胞来源的外泌体携带微小RNA-125a,通过靶向组蛋白去乙酰化酶1并下调内皮素-1来预防糖尿病肾病。
Diabetes Metab Syndr Obes. 2021 Mar 25;14:1405-1418. doi: 10.2147/DMSO.S286191. eCollection 2021.
6
Mesenchymal Stem Cell-Derived Exosomes: A Promising Biological Tool in Nanomedicine.间充质干细胞衍生的外泌体:纳米医学中一种有前景的生物工具。
Front Pharmacol. 2021 Jan 25;11:590470. doi: 10.3389/fphar.2020.590470. eCollection 2020.
7
RETRACTED: BMSCs-derived exosomal microRNA-let-7a plays a protective role in diabetic nephropathy via inhibition of USP22 expression.撤回:BMSCs 来源的外泌体 microRNA-let-7a 通过抑制 USP22 表达在糖尿病肾病中发挥保护作用。
Life Sci. 2021 Mar 1;268:118937. doi: 10.1016/j.lfs.2020.118937. Epub 2020 Dec 24.
8
Effects of mesenchymal stem cells transplantation on multiple sclerosis patients.间充质干细胞移植对多发性硬化症患者的影响。
Neuropeptides. 2020 Dec;84:102095. doi: 10.1016/j.npep.2020.102095. Epub 2020 Sep 17.
9
Exosomes: key players in cancer and potential therapeutic strategy.外泌体:癌症中的关键角色和潜在的治疗策略。
Signal Transduct Target Ther. 2020 Aug 5;5(1):145. doi: 10.1038/s41392-020-00261-0.
10
Adipose mesenchymal stem cell-derived extracellular vesicles containing microRNA-26a-5p target TLR4 and protect against diabetic nephropathy.脂肪间充质干细胞来源的细胞外囊泡含有 microRNA-26a-5p,可靶向 TLR4 并预防糖尿病肾病。
J Biol Chem. 2020 Sep 11;295(37):12868-12884. doi: 10.1074/jbc.RA120.012522. Epub 2020 Jun 24.